Palisade Bio Faces Delisting Concerns

Ticker: PALI · Form: 8-K · Filed: May 2, 2025 · CIK: 1357459

Palisade Bio, Inc. 8-K Filing Summary
FieldDetail
CompanyPalisade Bio, Inc. (PALI)
Form Type8-K
Filed DateMay 2, 2025
Risk Levelhigh
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, compliance

TL;DR

Palisade Bio might get delisted, check exchange rules.

AI Summary

Palisade Bio, Inc. filed an 8-K on May 2, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of April 29, 2025. The company, formerly known as Seneca Biopharma, Inc. and Neuralstem, Inc., is based in Carlsbad, California.

Why It Matters

This filing indicates potential issues with meeting stock exchange listing requirements, which could lead to the company's shares being delisted, impacting liquidity and investor confidence.

Risk Assessment

Risk Level: high — Delisting notices are a significant red flag for investors, indicating potential financial distress or non-compliance with exchange rules.

Key Players & Entities

  • PALISADE BIO, INC. (company) — Registrant
  • Seneca Biopharma, Inc. (company) — Former company name
  • Neuralstem, Inc. (company) — Former company name
  • 20250429 (date) — Date of earliest event reported
  • 20250502 (date) — Filing date

FAQ

What specific listing rule or standard has Palisade Bio, Inc. failed to satisfy?

The filing does not specify the exact rule or standard that was not met, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.

When was the earliest event reported in this 8-K filing?

The earliest event reported is dated April 29, 2025.

What is the principal executive office address for Palisade Bio, Inc.?

The principal executive offices are located at 7750 El Camino Real, Suite 2A, Carlsbad, California, 92009.

What were Palisade Bio, Inc.'s former company names?

Palisade Bio, Inc. was formerly known as Seneca Biopharma, Inc. and prior to that, Neuralstem, Inc.

What is the SEC file number for Palisade Bio, Inc.?

The SEC file number for Palisade Bio, Inc. is 001-33672.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 2, 2025 regarding PALISADE BIO, INC. (PALI).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.